Phase II trial of methylglyoxal-bis (guanylhydrazone) (MGBG) in patients with refractory multiple myeloma: An eastern cooperative oncology group (ECOG) study

Jane N. Winter*, Paul S. Ritch, Steven T. Rosen, Martin M. Oken, Janet M. Wolter, Peter H. Wiernik, Michael J. O'connell

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II trial of methylglyoxal-bis (guanylhydrazone) (MGBG) in patients with refractory multiple myeloma: An eastern cooperative oncology group (ECOG) study'. Together they form a unique fingerprint.

INIS

Pharmacology, Toxicology and Pharmaceutical Science